These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35545405)

  • 1. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
    Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway.
    Zhang MX; Xu XM; Zhang P; Han NN; Deng JJ; Yu TT; Gan YY; He XQ; Long ZX
    Tumour Biol; 2016 Feb; 37(2):2023-35. PubMed ID: 26337275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
    Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M
    Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEK2 Promotes Hepatoma Metastasis and Serves as Biomarker for High Recurrence Risk after Hepatic Resection.
    Chang YY; Yen CJ; Chan SH; Chou YW; Lee YP; Bao CY; Huang CJ; Huang W
    Ann Hepatol; 2018 Aug; 17(5):843-856. PubMed ID: 30145571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.
    Wen S; Liu Y; Yang M; Yang K; Huang J; Feng D
    Oncol Rep; 2016 Oct; 36(4):2193-9. PubMed ID: 27509921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma.
    Deng L; Sun J; Chen X; Liu L; Wu D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):316. PubMed ID: 31319849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIMA related kinase 2 promotes gastric cancer cell proliferation
    Fan WD; Chen T; Liu PJ
    World J Gastroenterol; 2019 Jun; 25(23):2898-2910. PubMed ID: 31249448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo.
    Wang S; Zhang C; Li Y; Li P; Zhang D; Li C
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):519-530. PubMed ID: 30542770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
    Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
    J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
    Wu SM; Lin SL; Lee KY; Chuang HC; Feng PH; Cheng WL; Liao CJ; Chi HC; Lin YH; Tsai CY; Chen WJ; Yeh CT; Lin KH
    Int J Cancer; 2017 Apr; 140(7):1581-1596. PubMed ID: 27925179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.
    Xing Z; Zhang M; Wang X; Liu J; Liu G; Feng K; Wang X
    J Mol Histol; 2021 Aug; 52(4):809-821. PubMed ID: 34009515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.
    Sun Y; Cao FL; Qu LL; Wang ZM; Liu XY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1459-1467. PubMed ID: 30840267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.
    Zhang Y; Wang W; Wang Y; Huang X; Zhang Z; Chen B; Xie W; Li S; Shen S; Peng B
    Oncol Rep; 2018 Mar; 39(3):1023-1033. PubMed ID: 29399700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation.
    Lai XB; Nie YQ; Huang HL; Li YF; Cao CY; Yang H; Shen B; Feng ZQ
    Oncol Lett; 2017 Mar; 13(3):1587-1594. PubMed ID: 28454295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
    Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
    Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Li GM; Liang CJ; Zhang DX; Zhang LJ; Wu JX; Xu YC
    Chin Med J (Engl); 2018 Oct; 131(19):2320-2331. PubMed ID: 30246718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma.
    Li N; Jiang S; Fu R; Lv J; Yao J; Mai J; Hua X; Chen H; Liu J; Lu M
    Biomark Med; 2021 Apr; 15(5):347-358. PubMed ID: 33666519
    [No Abstract]   [Full Text] [Related]  

  • 20. High expression of NEK2 promotes gastric cancer progression via activating AKT signaling.
    Wan H; Xu L; Zhang H; Wu F; Zeng W; Li T
    J Physiol Biochem; 2021 Feb; 77(1):25-34. PubMed ID: 33201407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.